Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
KCNN2 encodes the small conductance calcium-activated potassium channel protein 2, also known as SK2 or KCa2.2. This is an integral membrane protein that forms a voltage-independent, calcium-activated potassium channel. The channel is composed of four subunits and includes calmodulin-binding domains; calmodulin remains constitutively attached to the C terminus and confers Ca²⁺ sensitivity to the channel. KCNN2 channels mediate voltage-independent transmembrane transfer of potassium ions activated solely by intracellular Ca²⁺ levels, not by changes in membrane potential. They play a critical role in regulating neuronal excitability by contributing to the slow component of synaptic afterhyperpolarization (AHP) following action potentials in neurons, modulating firing patterns and responsiveness to synaptic input patterns in both central nervous system neurons and cardiomyocytes, and in cardiac tissue integrating beat-to-beat changes in intracellular Ca²⁺ with membrane potential dynamics. Upregulation has been linked with atrial fibrillation pathophysiology.
Channel blocker
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Small conductance calcium-activated potassium channel protein 2 (SK2).